Literature DB >> 16735335

Management of hypertrophic cardiomyopathy.

Paolo Spirito1, Camillo Autore.   

Abstract

Entities:  

Mesh:

Year:  2006        PMID: 16735335      PMCID: PMC1471918          DOI: 10.1136/bmj.332.7552.1251

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  27 in total

Review 1.  The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms.

Authors:  J G Seidman; C Seidman
Journal:  Cell       Date:  2001-02-23       Impact factor: 41.582

Review 2.  American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines.

Authors:  Barry J Maron; William J McKenna; Gordon K Danielson; Lukas J Kappenberger; Horst J Kuhn; Christine E Seidman; Pravin M Shah; William H Spencer; Paolo Spirito; Folkert J Ten Cate; E Douglas Wigle
Journal:  J Am Coll Cardiol       Date:  2003-11-05       Impact factor: 24.094

Review 3.  Clinical practice. Hypertrophic obstructive cardiomyopathy.

Authors:  Rick A Nishimura; David R Holmes
Journal:  N Engl J Med       Date:  2004-03-25       Impact factor: 91.245

Review 4.  Hypertrophic cardiomyopathy: a systematic review.

Authors:  Barry J Maron
Journal:  JAMA       Date:  2002-03-13       Impact factor: 56.272

5.  Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy.

Authors:  Franco Cecchi; Iacopo Olivotto; Roberto Gistri; Roberto Lorenzoni; Giampaolo Chiriatti; Paolo G Camici
Journal:  N Engl J Med       Date:  2003-09-11       Impact factor: 91.245

6.  Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance.

Authors:  James C C Moon; William J McKenna; Jane A McCrohon; Perry M Elliott; Gillian C Smith; Dudley J Pennell
Journal:  J Am Coll Cardiol       Date:  2003-05-07       Impact factor: 24.094

7.  Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy.

Authors:  Martin S Maron; Iacopo Olivotto; Sandro Betocchi; Susan A Casey; John R Lesser; Maria A Losi; Franco Cecchi; Barry J Maron
Journal:  N Engl J Med       Date:  2003-01-23       Impact factor: 91.245

Review 8.  Clinical course and prognosis of hypertrophic cardiomyopathy in an outpatient population.

Authors:  P Spirito; F Chiarella; L Carratino; M Z Berisso; P Bellotti; C Vecchio
Journal:  N Engl J Med       Date:  1989-03-23       Impact factor: 91.245

9.  Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients.

Authors:  Lorenzo Monserrat; Perry M Elliott; Juan R Gimeno; Sanjay Sharma; Manuel Penas-Lado; William J McKenna
Journal:  J Am Coll Cardiol       Date:  2003-09-03       Impact factor: 24.094

10.  Risk associated with pregnancy in hypertrophic cardiomyopathy.

Authors:  Camillo Autore; Maria Rosa Conte; Marco Piccininno; Paola Bernabò; Giovanna Bonfiglio; Paolo Bruzzi; Paolo Spirito
Journal:  J Am Coll Cardiol       Date:  2002-11-20       Impact factor: 24.094

View more
  18 in total

1.  Hypertrophic cardiomyopathy. Combination of beta blockers and verapamil may be risky.

Authors:  Javier Borja; Iñaki Izquierdo; Josep Guindo
Journal:  BMJ       Date:  2006-07-08

Review 2.  Distribution of late gadolinium enhancement in various types of cardiomyopathies: Significance in differential diagnosis, clinical features and prognosis.

Authors:  Hiroshi Satoh; Makoto Sano; Kenichiro Suwa; Takeji Saitoh; Mamoru Nobuhara; Masao Saotome; Tsuyoshi Urushida; Hideki Katoh; Hideharu Hayashi
Journal:  World J Cardiol       Date:  2014-07-26

3.  Recent advances in diagnosis and management of hypertrophic cardiomyopathy.

Authors:  B B Siswanto; R Aryani
Journal:  Heart Asia       Date:  2009-01-01

4.  Hypertrophic cardiomyopathy. Sudden death is rare in young people with hypertrophic cardiomyopathy.

Authors:  David S Wald; Malcolm Law
Journal:  BMJ       Date:  2006-07-08

5.  Hypertrophic cardiomyopathy and sudden cardiac death.

Authors:  Konstantinos I Stroumpoulis; Ioannis N Pantazopoulos; Theodoros T Xanthos
Journal:  World J Cardiol       Date:  2010-09-26

Review 6.  Narrative review: harnessing molecular genetics for the diagnosis and management of hypertrophic cardiomyopathy.

Authors:  Libin Wang; Jonathan G Seidman; Christine E Seidman
Journal:  Ann Intern Med       Date:  2010-04-20       Impact factor: 25.391

Review 7.  Epigenetics and chromatin remodeling in adult cardiomyopathy.

Authors:  Salma Awad Mahmoud; Coralie Poizat
Journal:  J Pathol       Date:  2013-10       Impact factor: 7.996

8.  Risk stratification and prevention of sudden death in hypertrophic cardiomyopathy.

Authors:  Camillo Autore; Giovanni Quarta; Paolo Spirito
Journal:  Curr Treat Options Cardiovasc Med       Date:  2007-12

9.  Effects of tanshinone II A on the myocardial hypertrophy signal transduction system protein kinase B in rats.

Authors:  En-yuan Tu; Ya-guang Zhou; Zhao-hua Wang; Qian-sheng Liang; Guang-tian Yang
Journal:  Chin J Integr Med       Date:  2009-10-03       Impact factor: 1.978

10.  INDUCED PLURIPOTENT STEM CELLS FOR MODELLING ENERGETIC ALTERATIONS IN HYPERTROPHIC CARDIOMYOPATHY.

Authors:  Chrishan J A Ramachandra; K P Myu Mai Ja; Ying-Hsi Lin; Winston Shim; William A Boisvert; Derek J Hausenloy
Journal:  Cond Med       Date:  2019
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.